Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Homes | 25 | 2026 | 701 | 2.320 |
Why?
|
| Residence Characteristics | 6 | 2017 | 230 | 1.500 |
Why?
|
| Pediatric Obesity | 3 | 2016 | 131 | 1.130 |
Why?
|
| Environment | 3 | 2017 | 125 | 0.950 |
Why?
|
| Dementia | 6 | 2026 | 290 | 0.890 |
Why?
|
| Body Mass Index | 5 | 2017 | 903 | 0.860 |
Why?
|
| Stroke | 13 | 2023 | 1226 | 0.810 |
Why?
|
| Health Status | 3 | 2021 | 448 | 0.800 |
Why?
|
| Depression | 6 | 2026 | 910 | 0.750 |
Why?
|
| United States | 34 | 2026 | 8192 | 0.690 |
Why?
|
| Aged, 80 and over | 31 | 2026 | 5684 | 0.680 |
Why?
|
| Mexican Americans | 7 | 2015 | 14 | 0.660 |
Why?
|
| Antidepressive Agents | 3 | 2026 | 244 | 0.620 |
Why?
|
| Male | 55 | 2026 | 31435 | 0.600 |
Why?
|
| Food Supply | 2 | 2017 | 58 | 0.580 |
Why?
|
| Female | 56 | 2026 | 34459 | 0.580 |
Why?
|
| Aged | 39 | 2026 | 15155 | 0.570 |
Why?
|
| Analgesics, Opioid | 5 | 2026 | 531 | 0.530 |
Why?
|
| Cross-Sectional Studies | 18 | 2026 | 2742 | 0.500 |
Why?
|
| Medicare | 9 | 2026 | 629 | 0.500 |
Why?
|
| Humans | 70 | 2026 | 65872 | 0.500 |
Why?
|
| Statistics as Topic | 1 | 2017 | 147 | 0.490 |
Why?
|
| Fast Foods | 1 | 2016 | 13 | 0.470 |
Why?
|
| Models, Statistical | 3 | 2016 | 312 | 0.470 |
Why?
|
| Feeding and Eating Disorders | 3 | 2022 | 53 | 0.470 |
Why?
|
| Environment Design | 1 | 2016 | 23 | 0.460 |
Why?
|
| Social Isolation | 2 | 2026 | 40 | 0.460 |
Why?
|
| Multimorbidity | 2 | 2026 | 54 | 0.450 |
Why?
|
| Frailty | 3 | 2022 | 132 | 0.440 |
Why?
|
| Serotonin and Noradrenaline Reuptake Inhibitors | 2 | 2026 | 14 | 0.430 |
Why?
|
| Atrial Fibrillation | 4 | 2025 | 885 | 0.430 |
Why?
|
| Brain Ischemia | 5 | 2017 | 424 | 0.420 |
Why?
|
| California | 7 | 2017 | 178 | 0.410 |
Why?
|
| Models, Theoretical | 1 | 2016 | 274 | 0.410 |
Why?
|
| Memantine | 2 | 2024 | 22 | 0.400 |
Why?
|
| Epidemics | 1 | 2013 | 27 | 0.390 |
Why?
|
| Anticoagulants | 4 | 2025 | 529 | 0.380 |
Why?
|
| Cognitive Dysfunction | 3 | 2022 | 360 | 0.380 |
Why?
|
| Arthritis, Psoriatic | 2 | 2023 | 32 | 0.380 |
Why?
|
| Antipsychotic Agents | 2 | 2026 | 308 | 0.370 |
Why?
|
| Health Behavior | 1 | 2016 | 485 | 0.360 |
Why?
|
| Schools | 5 | 2017 | 170 | 0.340 |
Why?
|
| Spondylarthritis | 2 | 2023 | 39 | 0.340 |
Why?
|
| Antirheumatic Agents | 2 | 2024 | 228 | 0.330 |
Why?
|
| Child | 11 | 2024 | 4656 | 0.310 |
Why?
|
| Homes for the Aged | 3 | 2026 | 166 | 0.300 |
Why?
|
| Schizophrenia | 2 | 2021 | 279 | 0.290 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 165 | 0.290 |
Why?
|
| Middle Aged | 24 | 2026 | 18518 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2023 | 348 | 0.290 |
Why?
|
| Physical Fitness | 3 | 2017 | 93 | 0.290 |
Why?
|
| Ambulatory Care | 3 | 2025 | 318 | 0.270 |
Why?
|
| Pain | 3 | 2025 | 400 | 0.270 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 413 | 0.270 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2024 | 50 | 0.250 |
Why?
|
| Retrospective Studies | 12 | 2026 | 6956 | 0.250 |
Why?
|
| Sexism | 2 | 2024 | 30 | 0.250 |
Why?
|
| Sex Factors | 7 | 2024 | 995 | 0.250 |
Why?
|
| Loneliness | 1 | 2026 | 20 | 0.240 |
Why?
|
| Delirium | 2 | 2025 | 55 | 0.240 |
Why?
|
| Psychomotor Agitation | 1 | 2026 | 25 | 0.240 |
Why?
|
| Behavioral Symptoms | 1 | 2026 | 18 | 0.240 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2026 | 35 | 0.240 |
Why?
|
| Central Nervous System Agents | 1 | 2026 | 11 | 0.240 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2017 | 126 | 0.230 |
Why?
|
| Polypharmacy | 1 | 2026 | 67 | 0.230 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 202 | 0.230 |
Why?
|
| Stroke Rehabilitation | 2 | 2017 | 51 | 0.230 |
Why?
|
| Adolescent | 9 | 2024 | 6371 | 0.220 |
Why?
|
| Nootropic Agents | 1 | 2025 | 14 | 0.220 |
Why?
|
| Atrial Flutter | 1 | 2025 | 33 | 0.220 |
Why?
|
| Physical Education and Training | 2 | 2017 | 29 | 0.220 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 878 | 0.220 |
Why?
|
| Communication Barriers | 1 | 2025 | 72 | 0.220 |
Why?
|
| Regression Analysis | 5 | 2017 | 498 | 0.210 |
Why?
|
| Psychotropic Drugs | 1 | 2025 | 81 | 0.210 |
Why?
|
| Risk Factors | 11 | 2024 | 5477 | 0.210 |
Why?
|
| Insurance, Health | 2 | 2022 | 153 | 0.200 |
Why?
|
| Frail Elderly | 2 | 2022 | 115 | 0.200 |
Why?
|
| Texas | 7 | 2017 | 60 | 0.200 |
Why?
|
| Colorectal Neoplasms | 1 | 2026 | 290 | 0.190 |
Why?
|
| Restaurants | 2 | 2013 | 12 | 0.190 |
Why?
|
| Hospices | 1 | 2023 | 39 | 0.190 |
Why?
|
| Cohort Studies | 6 | 2026 | 2653 | 0.190 |
Why?
|
| Caregivers | 1 | 2026 | 299 | 0.180 |
Why?
|
| Hospice Care | 1 | 2023 | 75 | 0.180 |
Why?
|
| Bulimia | 1 | 2022 | 20 | 0.180 |
Why?
|
| Rheumatology | 1 | 2022 | 70 | 0.180 |
Why?
|
| Prescription Drug Misuse | 1 | 2022 | 20 | 0.180 |
Why?
|
| Activities of Daily Living | 4 | 2017 | 295 | 0.170 |
Why?
|
| Geography, Medical | 1 | 2021 | 5 | 0.170 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 121 | 0.170 |
Why?
|
| Age Factors | 7 | 2022 | 1595 | 0.170 |
Why?
|
| Quality of Life | 2 | 2021 | 1271 | 0.160 |
Why?
|
| Gender Identity | 1 | 2021 | 69 | 0.160 |
Why?
|
| Prevalence | 5 | 2026 | 1455 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2022 | 505 | 0.160 |
Why?
|
| Young Adult | 7 | 2024 | 4887 | 0.160 |
Why?
|
| Psychotic Disorders | 1 | 2021 | 150 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 375 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2021 | 711 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 170 | 0.150 |
Why?
|
| Adult | 12 | 2025 | 17595 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 227 | 0.150 |
Why?
|
| Anticonvulsants | 1 | 2020 | 104 | 0.150 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 214 | 0.150 |
Why?
|
| Social Determinants of Health | 1 | 2021 | 150 | 0.140 |
Why?
|
| Overweight | 2 | 2012 | 254 | 0.140 |
Why?
|
| Epilepsy | 1 | 2020 | 113 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2020 | 204 | 0.140 |
Why?
|
| Cluster Analysis | 2 | 2023 | 267 | 0.140 |
Why?
|
| Fibrinolytic Agents | 2 | 2017 | 184 | 0.140 |
Why?
|
| Mental Health Services | 1 | 2022 | 306 | 0.140 |
Why?
|
| Hypertension | 3 | 2021 | 618 | 0.130 |
Why?
|
| Minority Groups | 1 | 2019 | 143 | 0.130 |
Why?
|
| Substance-Related Disorders | 2 | 2022 | 760 | 0.130 |
Why?
|
| Comorbidity | 4 | 2025 | 1122 | 0.130 |
Why?
|
| Guideline Adherence | 3 | 2017 | 310 | 0.130 |
Why?
|
| Health Status Disparities | 2 | 2024 | 147 | 0.130 |
Why?
|
| Students | 1 | 2019 | 227 | 0.120 |
Why?
|
| Community-Based Participatory Research | 1 | 2017 | 63 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2026 | 5832 | 0.120 |
Why?
|
| Propensity Score | 1 | 2017 | 192 | 0.120 |
Why?
|
| Cognition Disorders | 2 | 2017 | 224 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 774 | 0.120 |
Why?
|
| Spatial Analysis | 1 | 2016 | 12 | 0.120 |
Why?
|
| Community Health Services | 1 | 2017 | 127 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2021 | 806 | 0.120 |
Why?
|
| Recovery of Function | 2 | 2015 | 293 | 0.110 |
Why?
|
| Noninvasive Ventilation | 1 | 2016 | 68 | 0.110 |
Why?
|
| Bias | 1 | 2016 | 117 | 0.110 |
Why?
|
| Hospitalization | 1 | 2022 | 1404 | 0.110 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 205 | 0.110 |
Why?
|
| Linear Models | 1 | 2016 | 405 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 922 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2022 | 827 | 0.100 |
Why?
|
| Multilevel Analysis | 2 | 2026 | 8 | 0.100 |
Why?
|
| Social Support | 1 | 2017 | 394 | 0.100 |
Why?
|
| Population Surveillance | 4 | 2017 | 210 | 0.100 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 96 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 349 | 0.100 |
Why?
|
| Obesity | 2 | 2013 | 1279 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2024 | 370 | 0.090 |
Why?
|
| Patient Discharge | 3 | 2022 | 523 | 0.090 |
Why?
|
| Health Promotion | 1 | 2017 | 524 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2022 | 3340 | 0.090 |
Why?
|
| Diet | 1 | 2016 | 540 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 266 | 0.090 |
Why?
|
| Telemedicine | 1 | 2017 | 379 | 0.090 |
Why?
|
| Policy | 1 | 2012 | 55 | 0.090 |
Why?
|
| Physical Examination | 2 | 2022 | 109 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 517 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2013 | 488 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 1570 | 0.080 |
Why?
|
| Geriatric Assessment | 2 | 2022 | 163 | 0.080 |
Why?
|
| Self Report | 2 | 2025 | 395 | 0.080 |
Why?
|
| Legislation, Food | 1 | 2010 | 3 | 0.080 |
Why?
|
| Nutritional Requirements | 1 | 2010 | 19 | 0.080 |
Why?
|
| Registries | 2 | 2026 | 935 | 0.080 |
Why?
|
| Food | 1 | 2010 | 76 | 0.070 |
Why?
|
| Beverages | 1 | 2010 | 70 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1299 | 0.070 |
Why?
|
| School Health Services | 1 | 2010 | 86 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 2500 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2022 | 757 | 0.070 |
Why?
|
| Puerto Rico | 1 | 2026 | 143 | 0.060 |
Why?
|
| Incidence | 3 | 2015 | 1434 | 0.060 |
Why?
|
| Cognition | 2 | 2023 | 515 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 2411 | 0.060 |
Why?
|
| SEER Program | 1 | 2025 | 76 | 0.060 |
Why?
|
| Warfarin | 1 | 2025 | 125 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2025 | 289 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2025 | 120 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2024 | 47 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2025 | 343 | 0.050 |
Why?
|
| Population Health | 1 | 2024 | 17 | 0.050 |
Why?
|
| Language | 1 | 2025 | 156 | 0.050 |
Why?
|
| Accidental Falls | 1 | 2025 | 130 | 0.050 |
Why?
|
| Censuses | 1 | 2023 | 18 | 0.050 |
Why?
|
| Fractures, Bone | 1 | 2025 | 138 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2017 | 1030 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 859 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2023 | 106 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2024 | 133 | 0.050 |
Why?
|
| Biological Products | 1 | 2024 | 93 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 287 | 0.050 |
Why?
|
| Georgia | 1 | 2022 | 92 | 0.050 |
Why?
|
| Educational Status | 1 | 2023 | 279 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 170 | 0.040 |
Why?
|
| Albumins | 1 | 2022 | 46 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2024 | 307 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2790 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2024 | 154 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 169 | 0.040 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 19 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 46 | 0.040 |
Why?
|
| Age of Onset | 1 | 2021 | 175 | 0.040 |
Why?
|
| Myocardial Revascularization | 1 | 2021 | 78 | 0.040 |
Why?
|
| Data Collection | 1 | 2022 | 384 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 889 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 408 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2021 | 179 | 0.040 |
Why?
|
| Cause of Death | 1 | 2021 | 221 | 0.040 |
Why?
|
| Mortality | 1 | 2021 | 162 | 0.040 |
Why?
|
| Psychometrics | 1 | 2022 | 397 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 149 | 0.040 |
Why?
|
| Patient Admission | 1 | 2021 | 200 | 0.040 |
Why?
|
| Medicare Part D | 1 | 2020 | 36 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2021 | 192 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2021 | 169 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 746 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 293 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 252 | 0.040 |
Why?
|
| Biomarkers | 1 | 2024 | 1506 | 0.030 |
Why?
|
| Aging | 1 | 2024 | 784 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 21 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1720 | 0.030 |
Why?
|
| Michigan | 1 | 2017 | 45 | 0.030 |
Why?
|
| Infant | 1 | 2022 | 1721 | 0.030 |
Why?
|
| Medicaid | 1 | 2021 | 379 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 3780 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1059 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 113 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 558 | 0.030 |
Why?
|
| Survivors | 1 | 2017 | 189 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 1274 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 127 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2019 | 535 | 0.030 |
Why?
|
| Crime | 1 | 2015 | 57 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 592 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 749 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 537 | 0.030 |
Why?
|
| Medical Records | 1 | 2015 | 140 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1117 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1165 | 0.030 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 32 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 1672 | 0.020 |
Why?
|
| Poverty | 1 | 2015 | 307 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 740 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2014 | 216 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 2325 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 420 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 319 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 420 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 849 | 0.020 |
Why?
|
| Los Angeles | 1 | 2010 | 14 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2116 | 0.020 |
Why?
|
| State Government | 1 | 2010 | 32 | 0.020 |
Why?
|
| Commerce | 1 | 2010 | 58 | 0.020 |
Why?
|